PortfoliosLab logoPortfoliosLab logo
CBE3.L vs. ABBV
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

CBE3.L vs. ABBV - Performance Comparison

The chart below illustrates the hypothetical performance of a €10,000 investment in iShares € Govt Bond 1-3yr UCITS ETF EUR (Acc) (CBE3.L) and AbbVie Inc. (ABBV). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Different Trading Currencies

CBE3.L is traded in EUR, while ABBV is traded in USD. To make them comparable, the ABBV values have been converted to EUR using the latest available exchange rates.

Returns By Period

In the year-to-date period, CBE3.L achieves a 0.13% return, which is significantly lower than ABBV's 1.20% return. Over the past 10 years, CBE3.L has underperformed ABBV with an annualized return of 0.36%, while ABBV has yielded a comparatively higher 18.12% annualized return.


CBE3.L

1D
0.04%
1M
0.24%
YTD
0.13%
6M
0.25%
1Y
0.94%
3Y*
2.70%
5Y*
0.81%
10Y*
0.36%

ABBV

1D
3.45%
1M
9.86%
YTD
1.20%
6M
0.23%
1Y
21.90%
3Y*
19.07%
5Y*
20.39%
10Y*
18.12%
*Multi-year figures are annualized to reflect compound growth (CAGR)

CBE3.L vs. ABBV - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
CBE3.L
iShares € Govt Bond 1-3yr UCITS ETF EUR (Acc)
0.13%2.27%3.11%3.46%-4.26%-0.83%-0.15%0.18%-0.33%0.06%
ABBV
AbbVie Inc.
1.20%17.29%26.71%-3.23%31.69%42.33%17.19%3.76%3.69%40.40%

Correlation

The correlation between CBE3.L and ABBV is 0.07, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.07

Correlation (3Y)
Calculated over the trailing 3-year period

0.02

Correlation (5Y)
Calculated over the trailing 5-year period

0.04

Correlation (10Y)
Calculated over the trailing 10-year period

0.02

Correlation (All Time)
Calculated using the full available price history since May 14, 2013

0.06

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

CBE3.L vs. ABBV — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CBE3.L
CBE3.L Risk / Return Rank: 2323
Overall Rank
CBE3.L Sharpe Ratio Rank: 2424
Sharpe Ratio Rank
CBE3.L Sortino Ratio Rank: 2323
Sortino Ratio Rank
CBE3.L Omega Ratio Rank: 2424
Omega Ratio Rank
CBE3.L Calmar Ratio Rank: 2121
Calmar Ratio Rank
CBE3.L Martin Ratio Rank: 2323
Martin Ratio Rank

ABBV
ABBV Risk / Return Rank: 6868
Overall Rank
ABBV Sharpe Ratio Rank: 7272
Sharpe Ratio Rank
ABBV Sortino Ratio Rank: 6666
Sortino Ratio Rank
ABBV Omega Ratio Rank: 6565
Omega Ratio Rank
ABBV Calmar Ratio Rank: 6868
Calmar Ratio Rank
ABBV Martin Ratio Rank: 6868
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

CBE3.L vs. ABBV - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for iShares € Govt Bond 1-3yr UCITS ETF EUR (Acc) (CBE3.L) and AbbVie Inc. (ABBV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


CBE3.LABBVDifference
Sharpe ratioReturn per unit of total volatility

-0.13

Sortino ratioReturn per unit of downside risk

-0.24

Omega ratioGain probability vs. loss probability

1.16

1.17

-0.01

Calmar ratioReturn relative to maximum drawdown

0.85

1.28

-0.43

Martin ratioReturn relative to average drawdown

2.81

2.96

-0.16

CBE3.L vs. ABBV - Sharpe Ratio Comparison

The current CBE3.L Sharpe Ratio is 0.79, which is comparable to the ABBV Sharpe Ratio of 0.92. The chart below compares the historical Sharpe Ratios of CBE3.L and ABBV, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


CBE3.LABBVDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.79

0.92

-0.13

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.53

0.86

-0.33

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.28

0.69

-0.40

Sharpe Ratio (All Time)

Calculated using the full available price history

0.44

0.76

-0.32

Drawdowns

CBE3.L vs. ABBV - Drawdown Comparison

The maximum CBE3.L drawdown since its inception was -6.12%, smaller than the maximum ABBV drawdown of -38.52%. Use the drawdown chart below to compare losses from any high point for CBE3.L and ABBV.


Loading charts...

Drawdown Indicators


CBE3.LABBVDifference

Max Drawdown

Largest peak-to-trough decline

-6.12%

-38.52%

+32.40%

Max Drawdown (1Y)

Largest decline over 1 year

-1.10%

-17.22%

+16.12%

Max Drawdown (3Y)

Largest decline over 3 years

-1.10%

-26.03%

+24.93%

Max Drawdown (5Y)

Largest decline over 5 years

-5.19%

-26.03%

+20.84%

Max Drawdown (10Y)

Largest decline over 10 years

-6.12%

-38.52%

+32.40%

Current Drawdown

Current decline from peak

-0.42%

-4.81%

+4.39%

Average Drawdown

Average peak-to-trough decline

-1.06%

-9.23%

+8.17%

Ulcer Index

Depth and duration of drawdowns from previous peaks

0.34%

7.41%

-7.07%

Volatility

CBE3.L vs. ABBV - Volatility Comparison

The current volatility for iShares € Govt Bond 1-3yr UCITS ETF EUR (Acc) (CBE3.L) is 0.41%, while AbbVie Inc. (ABBV) has a volatility of 6.69%. This indicates that CBE3.L experiences smaller price fluctuations and is considered to be less risky than ABBV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


CBE3.LABBVDifference

Volatility (1M)

Calculated over the trailing 1-month period

0.41%

6.69%

-6.28%

Volatility (6M)

Calculated over the trailing 6-month period

1.08%

17.75%

-16.67%

Volatility (1Y)

Calculated over the trailing 1-year period

1.19%

23.92%

-22.73%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

1.51%

23.73%

-22.22%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

1.28%

26.49%

-25.21%

Dividends

CBE3.L vs. ABBV - Dividend Comparison

CBE3.L has not paid dividends to shareholders, while ABBV's dividend yield for the trailing twelve months is around 3.00%.


PositionTTM20252024202320222021202020192018201720162015
ABBV
AbbVie Inc.
3.00%2.87%3.49%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%
CBE3.L
iShares € Govt Bond 1-3yr UCITS ETF EUR (Acc)
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


CBE3.L and ABBV have a correlation of 0.07, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

Portfolio Optimizer

Find the right allocation for CBE3.L and ABBV

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer